Leprosy in an Adopted Woman Diagnosed by Molecular Tools: A Case Report from a Non-Endemic Area

Author:

Beltrame Anna,Fargnoli Maria ConcettaORCID,Avanzi Charlotte,Sollima Laura,Pomari ElenaORCID,Mori Antonio,Longoni Silvia StefaniaORCID,Moro LuciaORCID,Orza Pierantonio,Jackson Mary,Perandin FrancescaORCID

Abstract

Coupled with its rarity in non-endemic areas, the clinical heterogeneity of leprosy makes diagnosis very challenging. We report a diagnosis of multibacillary leprosy in a 22-year-old Indian woman, adopted at the age of 10 and living in Italy. The patient presented with painful skin lesions on the face, trunk, and lower and upper extremities, associated with dysesthesia and a motor deficit in her left leg following corticosteroid therapy interruption. Histopathology results from the skin lesions suggested leprosy, but no acid-fast bacilli were identified. Molecular biology in a center specializing in tropical diseases confirmed the diagnosis, allowing prompt and adequate treatment. Genotype analysis allowed the identification of a genotype 1D of M. leprae, facilitating the epidemiological investigation of the plausible infection origin. No resistances to rifampicin, dapsone, or ofloxacin were detected. Leprosy will continue to exist in high-income nations, and the incidence may rise over time due to increasing migration and globalization. CARE guidelines were followed.

Funder

Italian Ministry of Health “Fondi Ricerca Corrente – L3P1”

Fondation Raoul Follereau

New York Community Trust for Research

European Union’s Horizon 2020 Research and Innovation Program

Publisher

MDPI AG

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy

Reference44 articles.

1. Leprosy now: Epidemiology, progress, challenges, and research gaps;Rodrigues;Lancet Infect Dis.,2011

2. Mycobacterium lepromatosis as a Second Agent of Hansen’s Disease;Deps;Front. Microbiol.,2021

3. World Health Organization (2022, October 01). Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. Available online: https://www.who.int/publications/i/item/9789290228509.

4. World Health Organization (2022, October 01). Global Leprosy (Hansen Disease) Update, 2020: Impact of COVID-19 on Global Leprosy Control. Available online: https://www.who.int/wer.

5. Beltrame, A., Barabino, G., Wei, Y., Clapasson, A., Orza, P., Perandin, F., Piubelli, C., Monteiro, G.B., Longoni, S.S., and Rodari, P. (2020). Leprosy in Refugees and Migrants in Italy and a Literature Review of Cases Reported in Europe between 2009 and 2018. Microorganisms, 8.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A case of leprosy in an immunocompromised traveller;Journal of Travel Medicine;2024-04-11

2. Dapsone/prednisone;Reactions Weekly;2023-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3